Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
- PMID: 10457148
- DOI: 10.1046/j.1365-2362.1999.00527.x
Oral folate enhances endothelial function in hyperhomocysteinaemic subjects
Abstract
Background: Elevated plasma homocysteine (Hcy) is a risk factor for vascular disease. A postulated mechanism is vascular endothelial damage by homocysteine. Hcy levels are inversely related to blood concentrations of folate and can be lowered by folate supplements. The effect of oral folic acid on endothelial function was investigated in healthy adults with mild hyperhomocysteinaemia.
Patients and methods: Eighteen healthy subjects (Hcy > 13 micromol L-1 at entry), from a screening population of 890 volunteers, were entered into a randomised double-blind placebo-controlled crossover study of oral folic acid (5 mg daily for six weeks) with a six week interval between treatments. Flow-mediated (endothelium-dependent) and (endothelial-independent) glyceryl trinitrate (GTN)-mediated brachial artery dilatation were measured by high resolution wall tracking.
Results: Folate supplementation enhanced endothelium-dependent responses (+0.08 +/- 0.05 vs. +0.04 +/- 0.04 mm, P = 0.015) but endothelium-independent responses (GTN) were unchanged. Folate reduced Hcy (8.7 +/- 2.5 vs. 12.1 +/- 3.6 micromol L-1).
Conclusion: High dose folic acid supplementation enhances endothelium-dependent vascular function and lowers plasma Hcy. This provides preliminary evidence that folate may have beneficial cardiovascular effects in adults with mild hyperhomocysteinaemia.
Comment in
-
Future for folates in cardiovascular disease.Eur J Clin Invest. 1999 Aug;29(8):657-8. doi: 10.1046/j.1365-2362.1999.00526.x. Eur J Clin Invest. 1999. PMID: 10457147 Review. No abstract available.
Similar articles
-
Folic acid improves arterial endothelial function in adults with hyperhomocystinemia.J Am Coll Cardiol. 1999 Dec;34(7):2002-6. doi: 10.1016/s0735-1097(99)00469-6. J Am Coll Cardiol. 1999. PMID: 10588216 Clinical Trial.
-
Improved vascular endothelial function after oral B vitamins: An effect mediated through reduced concentrations of free plasma homocysteine.Circulation. 2000 Nov 14;102(20):2479-83. doi: 10.1161/01.cir.102.20.2479. Circulation. 2000. PMID: 11076820 Clinical Trial.
-
Folate improves endothelial function in patients with coronary heart disease.Clin Chem Lab Med. 2003 Nov;41(11):1505-12. doi: 10.1515/CCLM.2003.231. Clin Chem Lab Med. 2003. PMID: 14656033 Clinical Trial.
-
Homocysteine and endothelial function in human studies.Semin Vasc Med. 2005 May;5(2):172-82. doi: 10.1055/s-2005-872402. Semin Vasc Med. 2005. PMID: 16047269 Review.
-
Hyperhomocysteinemia and cardiovascular risk in postmenopausal women: the role of folate supplementation.Clin Chem Lab Med. 2007;45(2):130-5. doi: 10.1515/CCLM.2007.067. Clin Chem Lab Med. 2007. PMID: 17311496 Review.
Cited by
-
Homocysteine and blood pressure.Curr Hypertens Rep. 2003 Feb;5(1):26-31. doi: 10.1007/s11906-003-0007-z. Curr Hypertens Rep. 2003. PMID: 12530932 Review.
-
Homocysteine levels in patients with stroke: clinical relevance and therapeutic implications.CNS Drugs. 2001;15(6):437-43. doi: 10.2165/00023210-200115060-00002. CNS Drugs. 2001. PMID: 11524022 Review.
-
Nitric oxide, atherosclerosis and the clinical relevance of endothelial dysfunction.Heart Fail Rev. 2003 Jan;8(1):71-86. doi: 10.1023/a:1022199021949. Heart Fail Rev. 2003. PMID: 12652161 Review.
-
Homocysteine and atherothrombosis: diagnosis and treatment.Curr Atheroscler Rep. 2003 Jul;5(4):276-83. doi: 10.1007/s11883-003-0050-x. Curr Atheroscler Rep. 2003. PMID: 12793968 Review.
-
Folic acid: a marker of endothelial function in type 2 diabetes?Vasc Health Risk Manag. 2005;1(1):79-83. doi: 10.2147/vhrm.1.1.79.58941. Vasc Health Risk Manag. 2005. PMID: 17319100 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical